• Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic 

      Di Ciaccio, Pietro; McCaughan, Georgia; Trotman, Judith; Ho, Phoebe Joy; Cheah, Chan Y.; Gangatharan, Shane; Wight, Joel; Ku, Matthew; Quach, Hang; Gasiorowski, Robin; Polizzotto, Mark N.; Prince, Henry Miles; Mulligan, Stephen; Tam, Constantine S.; Gregory, Gareth; Hapgood, Greg; Spencer, Andrew; Dickinson, Michael; Latimer, Maya; Johnston, Anna; Armytage, Tasman; Lee, Cindy; Cochrane, Tara; Berkhahn, Leanne; Weinkove, Robert; Doocey, Richard; Harrison, Simon J.; Webber, Nicholas; Lee, Hui-Peng; Chapman, Scott; Campbell, Belinda A.; Gibbs, Simon D. J.; Hamad, Nada
      Published 2020
      The COVID-19 pandemic poses a unique challenge to the care of patients with haematological malignancies. Viral pneumonia is known to cause disproportionately severe disease in patients with cancer, and patients with lymphoma, ...
      Article
    • Is it time for PET-guided therapy in follicular lymphoma. 

      Trotman, Judith; Pettitt, Andrew R
      Published 2021
      18F-fluorodeoxyglucose (FDG) Positron Emission Tomography-Computerised Tomography (PET) is now established as the gold-standard imaging modality for both staging and response assessment of follicular lymphoma (FL). In this ...
      Article
    • Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV‐2 variants, but preserved antigen‐specific T cell responses 

      Beaton, Brendan; Sasson, Sarah C.; Rankin, Katherine; Raedemaeker, Juliette; Wong, Alexander; Hastak, Priyanka; Phetsouphanh, Chansavath; Warden, Andrew; Klemm, Vera; Munier, C. Mee Ling; Hoppe, Alexandra Carey; Tea, Fiona; Pillay, Aleha; Stella, Alberto Ospina; Aggarwal, Anupriya; Lavee, Orly; Caterson, Ian D.; Turville, Stuart; Kelleher, Anthony D.; Brilot, Fabienne; Trotman, Judith
      Published 2022
      Patients with indolent lymphoma undertaking recurrent or continuous B cell suppression are at risk of severe COVID-19. Patients and healthy controls (HC; N=13) received 2 doses of BNT162b2: Follicular Lymphoma (FL; N=35) ...
      Article
    • The rising cost of anticancer drugs in Australia 

      Karikios, DemeJ; Schofield, Deborah; Salkeld, Glenn; Mann, Kristy P; Trotman, Judith; Stockler, Martin
      Published 2014-02-25
      Background: Anticancer drugs are often expensive and are contributing to the growing cost of cancer care. Concerns have been raised about the effect rising costs may have on availability of new anticancer drugs. Aim: This ...
      Open Access
      Article
    • Whimsical (Waldenstrom's Macroglobulinemia Study Involving CArt-wheeL): A Global Patient-Derived Data Registry Capturing Treatment, Quality of Life and COVID-19 Data 

      Tohidi-Esfahani, Ibrahim; Warden, Andrew; Malunis, Elena; deNardis, Peter Liburdi; Haurat, Javier; Black, Marita; Opat, Stephen; D'Sa, Shirley; Kersten, Marie José; Spearing, Ruth; Palomba, Maria Lia; Olszewski, Adam J; Harrington, Carl; Scott, Clare; Trotman, Judith
      Published 2020
      Introduction: Patient-derived data can increase breadth of knowledge in rare cancers like Waldenström's Macroglobulinemia (WM), including patient-reported outcomes (PROs). WhiMSICAL (Waldenström's Macroglobulinemia Study ...
      Article